Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abbreviated, Advisory, affirmative, AG, ample, apparent, ARZERRAtm, ASP, asserted, ASU, awaiting, battling, belimumab, biosimilar, BPCIA, Brazil, Cabilly, calendar, California, carefully, cascade, Central, cheaper, Circuit, clarity, CMS, Colin, compel, composition, contested, CPT, creative, David, deadline, defend, defending, detain, diminish, diminution, disagreed, dispute, EMA, essential, exploratory, fashion, feedback, fifteen, filling, flexibility, France, frequently, Germany, Goddard, hand, heading, heard, hearing, herewith, hired, Hope, idiopathic, imperative, incidental, Indemnification, inflammation, ITP, judged, language, long, Lonza, managerial, mandated, margin, mediated, Medicaid, Medicare, Merck, month, Myriad, NDA, nonexistent, ofatumumab, opportunity, passage, pediatric, permanent, permission, PPACA, pre, predominantly, Procedural, Procedure, procure, purpura, quantity, quickly, reallocate, rebrand, recall, reclassification, RegistrationNo, rejected, relevant, repeatedly, reputation, revoke, route, Russia, SA, safer, seize, Serono, slightly, sound, Southwell, Spain, specialty, speed, standby, Strength, sublessee, suit, Switzerland, Terminology, thrombocytopenic, trained, transplant, triple, tripling, ulcerative, unavailability, unclassified, unenforceable, unique, unproductive, urgency, verge, vigilant, Waldenstrom, warning, withdrew
Removed:
Amgen, analyzed, antagonist, anthracisprotective, arm, assistance, augment, Australian, Automated, Barabe, bone, book, Brewery, budgetary, burn, CAT, cGMP, chemotherapy, consisting, construed, controlled, controlling, decreasing, delinquent, direction, dosing, emerging, employer, exciting, Exclusion, expanded, exploring, filer, focused, genotype, greatest, grow, HCV, hematologic, hereto, hinder, III, incidence, individually, interferon, joint, Kirin, knowledge, launching, leasehold, manage, marketability, marketplace, marrow, Melbourn, men, military, momentum, monetization, moved, mutually, NSCLC, ofRegulation, orexin, outlicensing, peginterferon, percent, plasma, poor, predicted, prominent, promise, pulmonary, purification, ratified, reacquired, realize, receivable, renewal, represented, reversal, rheumatoid, ribavirin, RNA, seasoned, Shareholder, sharpened, sharply, shell, shorter, show, smaller, span, spun, subleased, suggested, sustain, SVR, Syncria, Takeda, thisForm, Timothy, unanticipated, underwriting, undetectable, unforeseen, unmet, viewed, virologic, vivotesting, Washington, women
Filing tables
Filing exhibits
Related press release
HGSI similar filings
Filing view
External links
EXHIBIT 21.1
Subsidiaries
Name | Jurisdiction of Incorporation | |
HGS France S.à r.l. | France | |
HGS International S.à r.l | Luxembourg | |
HGS Luxembourg LLC | Delaware | |
HGS Luxembourg LLC, S.C.S | Luxembourg | |
Human Genome Sciences Europe GmbH | Germany | |
Human Genome Sciences Pacific Pty Ltd. | Australia | |
Human Genome Sciences Spain, S.L. | Spain |